Lycia Therapeutics 10% Owner Venrock Healthcare Capital Partners III L.P. Buys $224K of Stock
Venrock Healthcare Capital Partners III L.P., 10% Owner, bought 8,305 shares of Lycia Therapeutics, Inc. at $26.95 a share, worth $224K in total on Nov 2, 2026. Shares held after the trade: 6,858,542 (+0.1%).
Lycia Therapeutics 10% Owner Venrock Healthcare Capital Partners III L.P. Buys $639K of Stock
Venrock Healthcare Capital Partners III L.P., 10% Owner, bought 24,804 shares of Lycia Therapeutics, Inc. at $25.23 to $26.33 a share (average $25.78) in 4 transactions, worth $639K in total between Oct 28, 2026 and Oct 30, 2026. Shares held after the trade: 6,850,037 (+0.1%).
Lycia Therapeutics 10% Owner Venrock Healthcare Capital Partners III L.P. Buys $37.7M of Stock
Venrock Healthcare Capital Partners III L.P., 10% Owner, bought 2,045,440 shares of Lycia Therapeutics, Inc. at $18.00 to $26.97 a share (average $18.41) in 6 transactions, worth $37.7M in total between Oct 23, 2026 and Oct 27, 2026. Shares held after the trade: 6,825,233 (+0.5%).
Lycia Therapeutics, Inc. filed its Amended and Restated Certificate of Incorporation and Bylaws in connection with the closing of its initial public offering. These governance changes were previously approved by the board and stockholders to take effect upon the IPO's completion.